RecruitingNot Applicable

Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?

Austria30 participantsStarted 2025-11-05

Plain-language summary

During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pulmonary lesion suspicious for lung cancer or histologically confirmed lung cancer * indication for mediastinal staging Exclusion Criteria: \-

What they're measuring

Agreement between the two rounds of EBUS staging

Timeframe: 18 months

Trial details

NCT IDNCT07418450

SponsorUniversity of Vienna

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-05

Contact for this trial

Daniela Gompelmann

0043 1 40400 47730 daniela.gompelmann@meduniwien.ac.at

View on ClinicalTrials.gov More Lung Cancer (Diagnosis) trials